Sales revenue from the Company’s new products launched through the R&D amounted to RMB1.54 billion, representing 12.40% of the Company’s manufacturing sales revenue. Shanghai Pharmaceuticals continued to optimize its R&D system, founded an R&D management …
( read original story …)